DMAPT is primarily investigated for its potential in cancer therapy, particularly in targeting cancer stem cells. It is known to inhibit the Hedgehog signaling pathway, which plays a crucial role in the growth and proliferation of certain cancers. By disrupting this pathway, DMAPT may help reduce tumor growth and prevent cancer recurrence. It is being studied in preclinical and clinical settings for its efficacy in treating various cancers, including pancreatic, breast, and glioblastoma. Additionally, its role in enhancing the effectiveness of conventional chemotherapy and radiation therapy is under exploration. Research is ongoing to determine its safety, dosage, and long-term impact in cancer treatment.